Medicare updates oral Rx demonstration
Executive Summary
Pfizer's Somavert (pegvisomant) for treatment of acromegaly and Baxter's Mesnex (mesna) for reduction of ifosfamide-induced hemorrhagic cystitis will be reimbursed by the Medicare Part B replacement drug demonstration under an 1updated list of covered drugs. The original list of drugs included thirteen for oncology and fourteen for other indications (2"The Pink Sheet" June 28, 2004, p. 23)...
You may also be interested in...
Medicare Part B Oral Chemotherapy Demo To Cover Tamoxifen, Thalidomide
Tamoxifen and thalidomide will be covered under the Medicare Part B oral drug replacement demonstration project, the Centers for Medicare & Medicaid Services said in announcing the start of the project June 24
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.